Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [41] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Edgell, ET
    Kennedy, L
    Lepine, JP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
  • [42] Premorbid Personality Factors in Schizophrenia and Bipolar Disorder: Results From a Large Cohort Study of Male Conscripts
    Lonnqvist, Jan-Erik
    Verkasalo, Markku
    Haukka, Jari
    Nyman, Kai
    Tiihonen, Jari
    Laaksonen, Ilmo
    Leskinen, Jukka
    Lonnqvist, Jouko
    Henriksson, Markus
    JOURNAL OF ABNORMAL PSYCHOLOGY, 2009, 118 (02) : 418 - 423
  • [43] Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
    Fond, G.
    Korchia, T.
    de Verville, P. L. Sunhary
    Godin, O.
    Schurhoff, F.
    Berna, F.
    Andre, M.
    Aouizerate, B.
    Capdevielle, D.
    Chereau, I.
    D'Amato, T.
    Dubertret, C.
    Dubreucq, J.
    Leignier, S.
    Mallet, J.
    Misdrahi, D.
    Passerieux, C.
    Pignon, B.
    Rey, R.
    Szoke, A.
    Urbach, M.
    Vidailhet, P.
    Leboyer, M.
    Llorca, P. M.
    Lancon, C.
    Boyer, L.
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 274 : 617 - 623
  • [44] Change in clinical status, social functioning, weight and sexual adverse events over the first 6 months of treatment: pan-european results from the schizophrenia outpatient health outcomes (SOHO) study
    V Mavreas
    D Novick
    S Tzivelekis
    M Ratcliffe
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [45] Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study
    Bobes, Julio
    Arango, Celso
    Garcia-Garcia, Margarida
    Rejas, Javier
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 280 - 286
  • [46] Efficacy of antipsychotic treatment in schizophrenia: results after 24 months in Italian patients in the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Brugnoli, R.
    Novick, D.
    Frediani, S.
    Rossi, A.
    Suarez, D.
    Haro, J. M.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2007, 13 (03): : 330 - 340
  • [47] Clinical and functional status, weight and sexual adverse events over the first six months of treatment: Greek results from the schizophrenia outpatient health outcomes (SOHO) study
    V Mavreas
    C Touloumis
    D Novick
    S Tzivelekis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [48] Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia
    Karagianis, Jamie
    Williams, Richard
    Davis, Lori
    Procyshyn, Ric
    Monga, Neerav
    Hanley, James
    Chandrasena, Ranjith
    Thakur, Aruna
    Dickson, Ruth
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (09) : 2121 - 2132
  • [49] Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study
    Daniel Sechter
    Joseph Peuskens
    Odile Fleurot
    Werner Rein
    Yves Lecrubier
    Neuropsychopharmacology, 2002, 27 : 1071 - 1081
  • [50] Amisulpride vs. risperidone in chronic schizophrenia: Results of a 6-month double-blind study
    Sechter, D
    Peuskens, J
    Fleurot, O
    Rein, W
    Lecrubier, Y
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (06) : 1071 - 1081